{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,24]],"date-time":"2026-06-24T04:47:27Z","timestamp":1782276447771,"version":"3.54.5"},"reference-count":13,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Affective Disorders"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.jad.2026.121351","type":"journal-article","created":{"date-parts":[[2026,2,5]],"date-time":"2026-02-05T00:52:37Z","timestamp":1770252757000},"page":"121351","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Recommendations for repeated dosings of ketamine\/esketamine rest on an uncertain evidence base. Response to"],"prefix":"10.1016","volume":"402","author":[{"given":"Martin","family":"Pl\u00f6derl","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Florian","family":"Naudet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jad.2026.121351_bb0005","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3310\/eme04020","article-title":"Randomised controlled trial of ketamine augmentation of electroconvulsive therapy to improve neuropsychological and clinical outcomes in depression (Ketamine-ECT study)","volume":"4","author":"Anderson","year":"2017","journal-title":"Efficacy Mech. Eval."},{"key":"10.1016\/j.jad.2026.121351_bb0010","doi-asserted-by":"crossref","DOI":"10.1016\/j.pnpbp.2024.111152","article-title":"Efficacy of single and repeated ketamine administration for suicidal ideation in adults with psychiatric disorders: a meta-analysis","volume":"136","author":"Feng","year":"2025","journal-title":"Prog. Neuro-Psychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.jad.2026.121351_bb0015","doi-asserted-by":"crossref","DOI":"10.1001\/jamapsychiatry.2025.3019","article-title":"Serial ketamine infusions as adjunctive therapy to inpatient care for depression: the KARMA-Dep 2 randomized clinical trial","author":"Jelovac","year":"2025","journal-title":"JAMA Psychiatr."},{"key":"10.1016\/j.jad.2026.121351_bb0020","article-title":"A systematic review of ketamine and esketamine-induced long-term potentiation and synaptic scaling: do the molecular and synaptic plasticity effects inform dosing intervals?","author":"Le","year":"2025","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.jad.2026.121351_bb0025","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1038\/s44220-023-00140-x","article-title":"Randomized trial of ketamine masked by surgical anesthesia in patients with depression","volume":"1","author":"Lii","year":"2023","journal-title":"Nat. Ment. Health"},{"key":"10.1016\/j.jad.2026.121351_bb0030","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1186\/s12916-025-04435-x","article-title":"Efficacy and safety of esketamine for \u201ctreatment resistant depression\u201d: registered report for a systematic review with an individual patient data meta-analysis of randomized, double-blind, placebo-controlled trials","volume":"23","author":"Naudet","year":"2025","journal-title":"BMC Med."},{"key":"10.1016\/j.jad.2026.121351_bb0035","doi-asserted-by":"crossref","first-page":"1672","DOI":"10.3390\/brainsci13121672","article-title":"An update on the efficacy of single and serial intravenous ketamine infusions and esketamine for bipolar depression: a systematic review and meta-analysis","volume":"13","author":"Nunez","year":"2023","journal-title":"Brain Sci."},{"key":"10.1016\/j.jad.2026.121351_bb0040","series-title":"Effects of Ketamine and Esketamine on Death, Suicidal Behaviour, and Suicidal Ideation in Psychiatric Disorders: A Systematic Review and Meta-analysis","author":"Pl\u00f6derl","year":"2025"},{"key":"10.1016\/j.jad.2026.121351_bb0045","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1038\/s41398-020-00897-0","article-title":"A randomized, double-blind, active placebo-controlled study of efficacy, safety, and durability of repeated vs single subanesthetic ketamine for treatment-resistant depression","volume":"10","author":"Shiroma","year":"2020","journal-title":"Transl. Psychiatry"},{"key":"10.1016\/j.jad.2026.121351_bb0050","doi-asserted-by":"crossref","DOI":"10.1177\/20451253231198466","article-title":"History repeating: guidelines to address common problems in psychedelic science","volume":"13","author":"Van Elk","year":"2023","journal-title":"Ther. Adv. Psychopharmacol."},{"key":"10.1016\/j.jad.2026.121351_bb0055","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1176\/appi.ajp.2018.18020138","article-title":"Attenuation of antidepressant effects of ketamine by opioid receptor antagonism","volume":"175","author":"Williams","year":"2018","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.jad.2026.121351_bb0060","doi-asserted-by":"crossref","first-page":"1900","DOI":"10.1038\/s41386-018-0084-y","article-title":"(2R,6R)-Hydroxynorketamine is not essential for the antidepressant actions of (R)-ketamine in mice","volume":"43","author":"Yamaguchi","year":"2018","journal-title":"Neuropsychopharmacology"},{"issue":"6","key":"10.1016\/j.jad.2026.121351_bb5000","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1523\/JNEUROSCI.1316-22.2022","article-title":"NMDA receptor activation-dependent antidepressant-relevant behavioral and synaptic actions of ketamine","volume":"43","author":"Zanos","year":"2023","journal-title":"J. Neurosci."}],"container-title":["Journal of Affective Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165032726002028?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165032726002028?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,24]],"date-time":"2026-06-24T04:08:57Z","timestamp":1782274137000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165032726002028"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":13,"alternative-id":["S0165032726002028"],"URL":"https:\/\/doi.org\/10.1016\/j.jad.2026.121351","relation":{},"ISSN":["0165-0327"],"issn-type":[{"value":"0165-0327","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Recommendations for repeated dosings of ketamine\/esketamine rest on an uncertain evidence base. Response to","name":"articletitle","label":"Article Title"},{"value":"Journal of Affective Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jad.2026.121351","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"121351"}}